These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 30552711)
1. miR-186 inhibits proliferation, migration, and epithelial-mesenchymal transition in breast cancer cells by targeting Twist1. Sun WJ; Zhang YN; Xue P J Cell Biochem; 2019 Jun; 120(6):10001-10009. PubMed ID: 30552711 [TBL] [Abstract][Full Text] [Related]
2. miR-326 regulates EMT and metastasis of endometrial cancer through targeting TWIST1. Liu W; Zhang B; Xu N; Wang MJ; Liu Q Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3787-3793. PubMed ID: 28975990 [TBL] [Abstract][Full Text] [Related]
3. Circular RNA CNOT2 knockdown regulates twist family BHLH transcription factor via targeting microRNA 409-3p to prevent breast cancer invasion, migration and epithelial-mesenchymal transition. Su Q; Shen H; Gu B; Zhu N Bioengineered; 2021 Dec; 12(1):9058-9069. PubMed ID: 34698000 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion. Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483 [TBL] [Abstract][Full Text] [Related]
5. Regulation of cell growth and migration by miR-96 and miR-183 in a breast cancer model of epithelial-mesenchymal transition. Anderson O; Guttilla Reed IK PLoS One; 2020; 15(5):e0233187. PubMed ID: 32396572 [TBL] [Abstract][Full Text] [Related]
6. MiR-526b suppresses cell proliferation, cell invasion and epithelial-mesenchymal transition in breast cancer by targeting Twist1. Liu YQ; Cong YZ; Jiang J; Sheng JZ; Li XH; Zhao M; Peng MY Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3113-3121. PubMed ID: 32271429 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer. Yu Y; Zhao Y; Sun XH; Ge J; Zhang B; Wang X; Cao XC Oncotarget; 2015 Oct; 6(33):34423-36. PubMed ID: 26460733 [TBL] [Abstract][Full Text] [Related]
8. miR-934 promotes breast cancer metastasis by regulation of PTEN and epithelial-mesenchymal transition. Lu Y; Hu X; Yang X Tissue Cell; 2021 Aug; 71():101581. PubMed ID: 34147851 [TBL] [Abstract][Full Text] [Related]
9. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2. Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542 [TBL] [Abstract][Full Text] [Related]
10. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1. Li LZ; Zhang CZ; Liu LL; Yi C; Lu SX; Zhou X; Zhang ZJ; Peng YH; Yang YZ; Yun JP Carcinogenesis; 2014 Feb; 35(2):469-78. PubMed ID: 24085799 [TBL] [Abstract][Full Text] [Related]
11. microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1. Wang J; Wang X; Liu F; Fu Y Pharmazie; 2017 Aug; 72(8):475-481. PubMed ID: 29441907 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-361-5p inhibits epithelial-to-mesenchymal transition of glioma cells through targeting Twist1. Zhang X; Wei C; Li J; Liu J; Qu J Oncol Rep; 2017 Mar; 37(3):1849-1856. PubMed ID: 28184914 [TBL] [Abstract][Full Text] [Related]
13. miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells. Liu H; Wang H; Liu X; Yu T Biochem Biophys Res Commun; 2016 Apr; 472(2):346-52. PubMed ID: 26940738 [TBL] [Abstract][Full Text] [Related]
14. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25. Yin C; Mou Q; Pan X; Zhang G; Li H; Sun Y Thorac Cancer; 2018 Apr; 9(4):472-479. PubMed ID: 29524309 [TBL] [Abstract][Full Text] [Related]
15. TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation. Drasin DJ; Guarnieri AL; Neelakantan D; Kim J; Cabrera JH; Wang CA; Zaberezhnyy V; Gasparini P; Cascione L; Huebner K; Tan AC; Ford HL Cancer Res; 2015 May; 75(9):1908-21. PubMed ID: 25716682 [TBL] [Abstract][Full Text] [Related]
16. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1. Pei XH; Lv XQ; Li HX Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904 [TBL] [Abstract][Full Text] [Related]
17. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway. Tao Y; Han T; Zhang T; Ma C; Sun C Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582 [TBL] [Abstract][Full Text] [Related]
18. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging. Li Y; Chen G; Yan Y; Fan Q Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA ATB promotes the epithelial-mesenchymal transition by upregulating the miR-200c/Twist1 axe and predicts poor prognosis in breast cancer. Li RH; Chen M; Liu J; Shao CC; Guo CP; Wei XL; Li YC; Huang WH; Zhang GJ Cell Death Dis; 2018 Dec; 9(12):1171. PubMed ID: 30518916 [TBL] [Abstract][Full Text] [Related]
20. MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer. Luo LJ; Yang F; Ding JJ; Yan DL; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH Gene; 2016 Dec; 594(1):47-58. PubMed ID: 27593563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]